Related Experiment Video
Updated: Jun 16, 2026

Simple Establishment of a Vascularized Osteogenic Bone Marrow Niche Using Pre-Cast Poly(ethylene Glycol) (PEG) Hydrogels in an Imaging Microplate
Published on: May 19, 2023
Rho-kinase limits FGF-2-stimulated VEGF release in osteoblasts
Hideo Natsume1, Haruhiko Tokuda, Seiji Adachi
1Department of Orthopedic Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.
Abstract:
We previously reported that basic fibroblast growth factor (FGF-2) stimulates the release of vascular endothelial growth factor (VEGF) via p44/p42 mitogen-activated protein (MAP) kinase and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in osteoblast-like MC3T3-E1 cells and that FGF-2-activated p38 MAP kinase negatively regulates the VEGF release in osteoblast-like MC3T3-E1 cells. In the present study, we investigated whether Rho-kinase is involved in FGF-2-stimulated VEGF release in MC3T3-E1 cells. FGF-2 induced the phosphorylation of myosin phosphatase targeting subunit (MYPT-1), a substrate of Rho-kinase. Y27632, a specific inhibitor of Rho-kinase, which attenuated the MYPT-1 phosphorylation, significantly enhanced the FGF-2-stimulated VEGF release. Fasudil, another Rho-kinase inhibitor, also amplified the VEGF release. FGF-2 significantly stimulated VEGF accumulation and fasudil enhanced FGF-2-stimulated VEGF accumulation also in whole cell lysates. Neither Y27632 nor fasudil affected the phosphorylation levels of p44/p42 MAP kinase or p38 MAP kinase. Y27632 and fasudil markedly strengthened the FGF-2-induced phosphorylation of SAPK/JNK. Y27632 as well as fasudil enhanced FGF-2-stimulated VEGF release and Y27632 enhanced the FGF-2-induced phosphorylation levels of SAPK/JNK also in human osteoblasts. These results strongly suggest that Rho-kinase negatively regulates FGF-2-stimulated VEGF release in osteoblasts.
Insights
Rho-kinase negatively regulates vascular endothelial growth factor (VEGF) release stimulated by basic fibroblast growth factor (FGF-2) in osteoblasts. Inhibiting Rho-kinase enhances FGF-2-induced VEGF release and strengthens SAPK/JNK phosphorylation.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Basic fibroblast growth factor (FGF-2) influences osteoblast function.
- FGF-2 signaling involves mitogen-activated protein kinases (MAPKs) and regulates vascular endothelial growth factor (VEGF) release.
- Previous studies indicated complex regulation of VEGF release by different MAPK pathways in osteoblasts.
Purpose of the Study:
- To investigate the role of Rho-kinase in the regulation of FGF-2-stimulated VEGF release in osteoblast-like MC3T3-E1 cells.
- To determine the signaling pathways affected by Rho-kinase inhibition in response to FGF-2.
Main Methods:
- Utilized MC3T3-E1 cells and primary human osteoblasts.
- Administered FGF-2 and specific Rho-kinase inhibitors (Y27632, Fasudil).
- Assessed VEGF release, VEGF accumulation in cell lysates, and phosphorylation of key signaling proteins (MYPT-1, p44/p42 MAPK, p38 MAPK, SAPK/JNK).
Main Results:
- FGF-2 induced Rho-kinase activity, evidenced by MYPT-1 phosphorylation.
- Inhibition of Rho-kinase by Y27632 and Fasudil significantly enhanced FGF-2-stimulated VEGF release and accumulation.
- Rho-kinase inhibition did not affect p44/p42 or p38 MAPK phosphorylation but markedly strengthened FGF-2-induced SAPK/JNK phosphorylation.
- These findings were consistent in both MC3T3-E1 cells and human osteoblasts.
Conclusions:
- Rho-kinase acts as a negative regulator of FGF-2-stimulated VEGF release in osteoblasts.
- The inhibitory effect of Rho-kinase on VEGF release is mediated, at least in part, through modulation of the SAPK/JNK signaling pathway.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Amplifying Signals via Enzymatic Cascade
TGF - β Signaling Pathway
MAPK Signaling Cascades
GPCRs Regulate Adenylyl Cylase Activity
Two...
